Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2015 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Author reply: To PMID 24811963.
Cursiefen C, Viaud E. Cursiefen C, et al. Among authors: viaud e. Ophthalmology. 2015 May;122(5):e28-9. doi: 10.1016/j.ophtha.2014.10.018. Ophthalmology. 2015. PMID: 25919779 No abstract available.
Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study.
Cursiefen C, Viaud E, Bock F, Geudelin B, Ferry A, Kadlecová P, Lévy M, Al Mahmood S, Colin S, Thorin E, Majo F, Frueh B, Wilhelm F, Meyer-Ter-Vehn T, Geerling G, Böhringer D, Reinhard T, Meller D, Pleyer U, Bachmann B, Seitz B. Cursiefen C, et al. Among authors: viaud e. Ophthalmology. 2014 Sep;121(9):1683-92. doi: 10.1016/j.ophtha.2014.03.038. Epub 2014 May 6. Ophthalmology. 2014. PMID: 24811963 Free article. Clinical Trial.
Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical administration.
Cloutier F, Lawrence M, Goody R, Lamoureux S, Al-Mahmood S, Colin S, Ferry A, Conduzorgues JP, Hadri A, Cursiefen C, Udaondo P, Viaud E, Thorin E, Chemtob S. Cloutier F, et al. Among authors: viaud e. Invest Ophthalmol Vis Sci. 2012 Mar 9;53(3):1195-203. doi: 10.1167/iovs.11-9064. Invest Ophthalmol Vis Sci. 2012. PMID: 22323484